AllianceBernstein’s Lunai Bioworks LNAI Stock Holding History

AllianceBernstein’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-474	Closed	-$20.6K	–	3315
2025 Q1	$20.6K	Hold	474	–	–	﹤0.01%	3181
2024 Q4	$31.7K	Hold	474	–	–	﹤0.01%	3203
2024 Q3	$18.3K	Hold	474	–	–	﹤0.01%	3220
2024 Q2	$66.3K	Buy	+474	New	+$64.6K	﹤0.01%	3166
2023 Q2	–	Sell	-130	Closed	-$9.52K	–	3231
2023 Q1	$9.52K	Hold	130	–	–	﹤0.01%	3145
2022 Q4	$10.7K	Hold	130	–	–	﹤0.01%	3223
2022 Q3	$19K	Buy	+130	New	+$23.7K	﹤0.01%	3213
2021 Q2	–	Sell	-349	Closed	-$99K	–	3396
2021 Q1	$99K	Hold	349	–	–	﹤0.01%	3159
2020 Q4	$82K	Hold	349	–	–	﹤0.01%	3122
2020 Q3	$100K	Hold	349	–	–	﹤0.01%	3078
2020 Q2	$117K	Buy	+349	New	+$105K	﹤0.01%	3087

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

AllianceBernstein's LNAI Position: Q2 2025 in Review

AllianceBernstein sold out of Lunai Bioworks (LNAI) in Q2 2025, closing a stake of 474 shares — an estimated $20.6K sold.

AllianceBernstein first reported a position in LNAI in Q2 2020 and held it in 11 quarters. The position peaked at $117K in Q2 2020. 42 funds tracked by Wall St. Rank hold LNAI as of Q2 2025.

AllianceBernstein reported no remaining Lunai Bioworks position as of Q2 2025 after selling out during the quarter.
AllianceBernstein sold 474 Lunai Bioworks shares in Q2 2025, an estimated $20.6K.
AllianceBernstein first reported a position in Lunai Bioworks in Q2 2020 and held it in 11 quarters.
AllianceBernstein's Lunai Bioworks position peaked at $117K in Q2 2020.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.